BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17289837)

  • 1. Epothilone B inhibits neointimal formation after rat carotid injury through the regulation of cell cycle-related proteins.
    Lim Y; Kim TJ; Jin YR; Kim DW; Kwon JS; Son JH; Jung JC; Avery MA; Son DJ; Hong JT; Yun YP
    J Pharmacol Exp Ther; 2007 May; 321(2):648-55. PubMed ID: 17289837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epothilone D, a microtubule-stabilizing compound, inhibits neointimal hyperplasia after rat carotid artery injury by cell cycle arrest via regulation of G1-checkpoint proteins.
    Kim TJ; Lim Y; Kim DW; Kwon JS; Son JH; Jin YR; Son DJ; Jung JC; Avery MA; Hong JT; Yun YP
    Vascul Pharmacol; 2007 Oct; 47(4):229-37. PubMed ID: 17706465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tanshinone IIA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signaling pathway.
    Li X; Du JR; Yu Y; Bai B; Zheng XY
    J Ethnopharmacol; 2010 May; 129(2):273-9. PubMed ID: 20363310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation.
    Yang X; Thomas DP; Zhang X; Culver BW; Alexander BM; Murdoch WJ; Rao MN; Tulis DA; Ren J; Sreejayan N
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):85-90. PubMed ID: 16239599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury.
    Hur KY; Seo HJ; Kang ES; Kim SH; Song S; Kim EH; Lim S; Choi C; Heo JH; Hwang KC; Ahn CW; Cha BS; Jung M; Lee HC
    Eur J Pharmacol; 2008 May; 586(1-3):226-33. PubMed ID: 18387604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia.
    Dong LH; Wen JK; Miao SB; Jia Z; Hu HJ; Sun RH; Wu Y; Han M
    Cell Res; 2010 Nov; 20(11):1252-62. PubMed ID: 20661261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
    Gennaro G; Ménard C; Michaud SE; Deblois D; Rivard A
    Circulation; 2004 Nov; 110(21):3367-71. PubMed ID: 15520324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.
    Chen D; Krasinski K; Sylvester A; Chen J; Nisen PD; Andrés V
    J Clin Invest; 1997 May; 99(10):2334-41. PubMed ID: 9153274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceramide 1-phosphate induces neointimal formation via cell proliferation and cell cycle progression upstream of ERK1/2 in vascular smooth muscle cells.
    Kim TJ; Kang YJ; Lim Y; Lee HW; Bae K; Lee YS; Yoo JM; Yoo HS; Yun YP
    Exp Cell Res; 2011 Aug; 317(14):2041-51. PubMed ID: 21624361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoeugenodilol inhibits smooth muscle cell proliferation and neointimal thickening after balloon injury via inactivation of ERK1/2 pathway.
    Yeh JL; Liou SF; Chang YP; Lin SW; Liu TS; Wu BN; Chen IJ; Wu JR
    J Biomed Sci; 2008 May; 15(3):375-89. PubMed ID: 18247158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
    FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
    Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
    J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of OD 78 [3-(4-bromo-phenoxy)-4,5-dihydroxybenzoic acid-methyl ester] on the proliferation and migration of TNF-α-induced rat aortic smooth muscle cells.
    Lim Y; Tudev M; Park ES; Kim WS; Lim IH; Lee MY; Lee H; Jung JK; Hong JT; Yoo HS; Lee MK; Pyo MY; Yun YP
    Arch Pharm Res; 2011 Jul; 34(7):1191-9. PubMed ID: 21811927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound K, an intestinal metabolite of ginsenosides, inhibits PDGF-BB-induced VSMC proliferation and migration through G1 arrest and attenuates neointimal hyperplasia after arterial injury.
    Park ES; Lee KP; Jung SH; Lee DY; Won KJ; Yun YP; Kim B
    Atherosclerosis; 2013 May; 228(1):53-60. PubMed ID: 23473423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cudraflavanone A, a flavonoid isolated from the root bark of Cudrania tricuspidata, inhibits vascular smooth muscle cell growth via an Akt-dependent pathway.
    Han HJ; Kim TJ; Jin YR; Hong SS; Hwang JH; Hwang BY; Lee KH; Park TK; Yun YP
    Planta Med; 2007 Sep; 73(11):1163-8. PubMed ID: 17713875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. l-Caldesmon regulates proliferation and migration of vascular smooth muscle cells and inhibits neointimal formation after angioplasty.
    Yokouchi K; Numaguchi Y; Kubota R; Ishii M; Imai H; Murakami R; Ogawa Y; Kondo T; Okumura K; Ingber DE; Murohara T
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2231-7. PubMed ID: 16888241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clitocybin B inhibits rat aortic smooth muscle cell proliferation through suppressing PDGF-Rβ phosphorylation.
    Yoo KD; Park ES; Lim Y; Kang SI; Yoo SH; Won HH; Lee HP; Kim YH; Yoo ID; Yoo HS; Hong JT; Yun YP
    Vascul Pharmacol; 2012; 56(1-2):91-7. PubMed ID: 22166585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.
    Kim SY; Jeoung NH; Oh CJ; Choi YK; Lee HJ; Kim HJ; Kim JY; Hwang JH; Tadi S; Yim YH; Lee KU; Park KG; Huh S; Min KN; Jeong KH; Park MG; Kwak TH; Kweon GR; Inukai K; Shong M; Lee IK
    Circ Res; 2009 Apr; 104(7):842-50. PubMed ID: 19229058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vascular smooth muscle cell proliferation by the vitamin E derivative pentamethylhydroxychromane in an in vitro and in vivo study: pivotal role of hydroxyl radical-mediated PLCgamma1 and JAK2 phosphorylation.
    Hsieh CY; Liu CL; Hsu MJ; Jayakumar T; Chou DS; Wang YH; Hsiao G; Sheu JR
    Free Radic Biol Med; 2010 Sep; 49(5):881-93. PubMed ID: 20600839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.